Epigenetic inactivation of the MIR34B/C in multiple myeloma.
about
11q deletion in neuroblastoma: a review of biological and clinical implications.Diffuse large B-cell lymphoma with combined TP53 mutation and MIR34A methylation: Another "double hit" lymphoma with very poor outcome?MicroRNA: important player in the pathobiology of multiple myelomaEpigenetic alteration and microRNA dysregulation in cancerWhole-epigenome analysis in multiple myeloma reveals DNA hypermethylation of B cell-specific enhancers.Tumor-suppressive miR148a is silenced by CpG island hypermethylation in IDH1-mutant gliomas.Global epigenetic regulation of microRNAs in multiple myeloma.Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms.Epigenetic silencing of a long non-coding RNA KIAA0495 in multiple myeloma.Genome-wide pharmacologic unmasking identifies tumor suppressive microRNAs in multiple myeloma.Epigenetic inactivation of the MIR129-2 in hematological malignancies.Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia--implications on constitutive activation of NFκB pathway.Epigenetic inactivation of mir-34b/c in addition to mir-34a and DAPK1 in chronic lymphocytic leukemia.DNA methylation of microRNA genes in multiple myeloma.miRNAs as mediators of drug resistance.Methylation of tumor suppressor microRNAs: lessons from lymphoid malignancies.Aberrant microRNA expression in multiple myeloma.Non-coding RNA: a novel opportunity for the personalized treatment of multiple myeloma.Emerging pathways as individualized therapeutic target of multiple myeloma.The role of epigenetics in the biology of multiple myeloma.DNA methylation of tumor suppressor protein-coding and non-coding genes in multiple myeloma.Genetic and epigenetic alterations of microRNAs and implications for human cancers and other diseases.The roles of microRNA-34b-5p in angiogenesis of thyroid carcinoma.Epigenetic silencing of miR-137 induces drug resistance and chromosomal instability by targeting AURKA in multiple myeloma.Relationship Between Noncoding RNA Dysregulation and Epigenetic Mechanisms in Cancer.Infrequent DNA methylation of miR-9-1 and miR-9-3 in multiple myeloma.Upregulation of miR-362-3p Modulates Proliferation and Anchorage-Independent Growth by Directly Targeting Tob2 in Hepatocellular Carcinoma.Methylation of miR-155-3p in mantle cell lymphoma and other non-Hodgkin's lymphomas.Epigenetic inactivation of DAPK1, p14ARF, mir-34a and -34b/c in acute promyelocytic leukaemia.Epigenetic modifications in multiple myeloma: recent advances on the role of DNA and histone methylation.piRNA-823 contributes to tumorigenesis by regulating de novo DNA methylation and angiogenesis in multiple myeloma.Epigenetic silencing of LPP/miR-28 in multiple myeloma.
P2860
Q32174267-A95B7B30-8A02-4C55-9D4D-462C88C0BE5FQ33688416-E3404B7E-37B2-4546-AF6B-7F307E7BCDAAQ33786861-DD087CAF-B3AD-4A46-AB30-C57B6C2434D6Q34392645-9CEFB831-7B8D-46D7-8C0A-92E9FF41609EQ34460989-D22EB6FF-F29C-45F2-8129-550AEAEAA5BCQ34518462-05696C75-2325-4D2C-AEF6-3C61F4963F6AQ35350129-12E7740A-6520-4241-BE3E-57C547D0110AQ35768988-C60DCA24-7C4C-4820-899A-8E94D5947750Q36094729-D8EDD98E-7521-4FC7-9A89-591A22972D84Q36413501-C5CD0162-7461-4421-8CB4-A09040893540Q36621405-39D5A509-8FDC-4E2C-9063-CBD4108FC622Q37424922-2E92F848-E963-4F50-BDC6-BE5A021910B8Q37616347-D30B288A-1820-4818-9817-3CC227C82A38Q38020153-3C14DE9B-1B53-4CAA-80AB-71864E7C2657Q38037620-9740065A-0417-406E-8A91-9F0CAA355293Q38059899-8AA8354B-51CB-4956-89BF-C29067266962Q38099048-67342C4A-FA43-42BF-A86F-698B96F26B57Q38108387-98E2D66A-797D-452A-A8BD-BBE23D69765FQ38112176-153B560C-273F-4CAE-A641-06793184F145Q38208520-A3186630-6769-4FF7-ADDC-17B35FE05938Q38595057-3B639E98-FF4E-4BF0-B80C-7522EC10389EQ38664137-A514D03F-919E-4DF3-9A58-EECB20E3A9ADQ38694209-682A6B44-003B-43A6-BB24-3EE3BC46B3CEQ38730550-BD98B107-EF9A-4729-BC7E-DB42C5CB45AEQ38885469-2D8CFA9C-B565-4117-84E2-0742CF7EBF64Q38889464-294D061F-E163-4C89-9998-6E0F9FCD951AQ38913245-D9C22148-BBA9-42BC-9BD9-EF81E8B2B761Q38957493-1CCFD59A-F25D-4CCA-8671-6D117636F416Q38996899-17DD6F13-AC68-44BA-9E85-9B34D9580FF8Q39021977-8ECA7B7C-62C8-418E-BCE9-786D22C01D3EQ53239319-A951CDC6-A808-4A5B-AB17-E13268ED31D2Q55263293-B3A94FA4-34AA-4D8C-A1BC-E3D52056260D
P2860
Epigenetic inactivation of the MIR34B/C in multiple myeloma.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Epigenetic inactivation of the MIR34B/C in multiple myeloma.
@en
Epigenetic inactivation of the MIR34B/C in multiple myeloma.
@nl
type
label
Epigenetic inactivation of the MIR34B/C in multiple myeloma.
@en
Epigenetic inactivation of the MIR34B/C in multiple myeloma.
@nl
prefLabel
Epigenetic inactivation of the MIR34B/C in multiple myeloma.
@en
Epigenetic inactivation of the MIR34B/C in multiple myeloma.
@nl
P2093
P1433
P1476
Epigenetic inactivation of the MIR34B/C in multiple myeloma
@en
P2093
Chi Chiu So
Dong-Yan Jin
Raymond Liang
Rita Lok Hay Yim
P304
P356
10.1182/BLOOD-2011-06-361022
P407
P577
2011-10-05T00:00:00Z